Radius Health, Inc. (RDUS)

USD 29.43

(0.14%)

Revenue Summary of Radius Health, Inc.

  • Radius Health, Inc.'s latest annual revenue in 2023 was 2.88 Billion USD , down -17.32% from previous year.
  • Radius Health, Inc.'s latest quarterly revenue in 2023 FY was 2.88 Billion USD , down -17.32% from previous quarter.
  • Radius Health, Inc. reported a annual revenue of 3.48 Billion USD in annual revenue 2022, up 26.36% from previous year.
  • Radius Health, Inc. reported a annual revenue of 2.75 Billion USD in annual revenue 2021, up 61.1% from previous year.
  • Radius Health, Inc. reported a quarterly revenue of 755.95 Million USD for 2023 Q1, up 26.26% from previous quarter.
  • Radius Health, Inc. reported a quarterly revenue of 809.61 Million USD for 2023 Q2, up 7.1% from previous quarter.

Annual Revenue Chart of Radius Health, Inc. (2023 - 2008)

Historical Annual Revenue of Radius Health, Inc. (2023 - 2008)

Year Revenue Revenue Growth
2023 2.88 Billion USD -17.32%
2022 3.48 Billion USD 26.36%
2021 2.75 Billion USD 61.1%
2020 1.71 Billion USD 887.98%
2019 173.31 Million USD 74.65%
2018 99.23 Million USD 348.8%
2017 22.11 Million USD 0.0%
2016 - USD 0.0%
2015 - USD 0.0%
2014 - USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%

Peer Revenue Comparison of Radius Health, Inc.

Name Revenue Revenue Difference
ANI Pharmaceuticals, Inc. 486.81 Million USD -492.056%
Aquestive Therapeutics, Inc. 50.58 Million USD -5598.009%
Collegium Pharmaceutical, Inc. 566.76 Million USD -408.538%
Cosmos Health Inc. 53.37 Million USD -5299.762%
Cyclo Therapeutics, Inc. 1.07 Million USD -267663.899%
Esperion Therapeutics, Inc. 116.33 Million USD -2377.542%
Cronos Group Inc. 88.84 Million USD -3144.254%
Incannex Healthcare Limited 12 Thousand USD -24018433.333%
Kala Pharmaceuticals, Inc. - USD -Infinity%
Lifecore Biomedical, Inc. 128.26 Million USD -2147.155%
Regencell Bioscience Holdings Limited - USD -Infinity%
Sunshine Biopharma, Inc. 24.09 Million USD -11863.016%
Sunshine Biopharma, Inc. 24.09 Million USD -11863.016%
SCYNEXIS, Inc. 140.14 Million USD -1956.66%
Safety Shot Inc 202.67 Thousand USD -1422026.61%
Theratechnologies Inc. 81.76 Million USD -3425.053%
Alpha Teknova, Inc. 36.68 Million USD -7756.897%
Universe Pharmaceuticals INC 32.3 Million USD -8820.882%
Pacira BioSciences, Inc. 674.97 Million USD -327.01%
Sonoma Pharmaceuticals, Inc. 12.73 Million USD -22532.305%
Dynavax Technologies Corporation 232.28 Million USD -1140.819%
Ironwood Pharmaceuticals, Inc. 442.73 Million USD -551.004%
China SXT Pharmaceuticals, Inc. 1.92 Million USD -149354.42%
Alvotech 91.43 Million USD -3052.245%
Intra-Cellular Therapies, Inc. 464.37 Million USD -520.674%
SIGA Technologies, Inc. 139.91 Million USD -1959.949%
Shineco, Inc. 9.8 Million USD -29304.88%
Silver Spike Investment Corp. 11.72 Million USD -24487.88%
Journey Medical Corporation 79.18 Million USD -3540.045%
Petros Pharmaceuticals, Inc. 5.82 Million USD -49402.438%
Embecta Corp. 1.12 Billion USD -157.158%
Harrow Health, Inc. 130.19 Million USD -2113.809%
Procaps Group, S.A. 409.92 Million USD -603.119%
Biofrontera Inc. 34.07 Million USD -8359.464%
DURECT Corporation 8.54 Million USD -33618.109%
PainReform Ltd. - USD -Infinity%
Supernus Pharmaceuticals, Inc. 607.52 Million USD -374.424%
OptiNose, Inc. 70.98 Million USD -3960.214%
RedHill Biopharma Ltd. 6.51 Million USD -44152.225%
Organogenesis Holdings Inc. 433.14 Million USD -565.425%
Cumberland Pharmaceuticals Inc. 39.55 Million USD -7187.083%
ProPhase Labs, Inc. 44.38 Million USD -6393.836%
Phibro Animal Health Corporation 1.01 Billion USD -183.215%
Procaps Group S.A. 409.92 Million USD -603.119%
TherapeuticsMD, Inc. 1.3 Million USD -221268.971%
Viatris Inc. 15.42 Billion USD 81.317%
Rockwell Medical, Inc. 83.61 Million USD -3347.142%
Aytu BioPharma, Inc. 81 Million USD -3458.213%
Tilray Brands, Inc. 788.94 Million USD -265.328%
PetIQ, Inc. 1.1 Billion USD -161.554%
Talphera, Inc. 651 Thousand USD -442637.942%
Neurocrine Biosciences, Inc. 1.88 Billion USD -52.733%
Alimera Sciences, Inc. 80.75 Million USD -3469.141%
Assertio Holdings, Inc. 152.06 Million USD -1795.34%
Shuttle Pharmaceuticals Holdings, Inc. - USD -Infinity%
Avadel Pharmaceuticals plc 27.96 Million USD -10207.277%
Hempacco Co., Inc. 4.04 Million USD -71142.773%
Alvotech 91.43 Million USD -3052.245%
Lantheus Holdings, Inc. 1.29 Billion USD -122.32%
Kamada Ltd. 144.75 Million USD -1891.053%
Currenc Group, Inc. 53.25 Million USD -5312.082%
Indivior PLC 1.09 Billion USD -163.698%
Evoke Pharma, Inc. 5.18 Million USD -55534.624%
Flora Growth Corp. 76.07 Million USD -3688.86%
Cyclo Therapeutics, Inc. 1.07 Million USD -267663.899%
Evolus, Inc. 202.08 Million USD -1326.243%
HUTCHMED (China) Limited 837.99 Million USD -243.941%
Amphastar Pharmaceuticals, Inc. 644.39 Million USD -347.276%
Akanda Corp. 2.16 Million USD -133333.084%